Comprehensive genomic characterization of squamous cell lung cancers

Comprehensive genomic characterization of squamous cell lung cancers

ID:39711882

大小:512.27 KB

页数:8页

时间:2019-07-09

Comprehensive genomic characterization of squamous cell lung cancers_第1页
Comprehensive genomic characterization of squamous cell lung cancers_第2页
Comprehensive genomic characterization of squamous cell lung cancers_第3页
Comprehensive genomic characterization of squamous cell lung cancers_第4页
Comprehensive genomic characterization of squamous cell lung cancers_第5页
资源描述:

《Comprehensive genomic characterization of squamous cell lung cancers》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、ARTICLEdoi:10.1038/nature11404ComprehensivegenomiccharacterizationofsquamouscelllungcancersTheCancerGenomeAtlasResearchNetwork*Lungsquamouscellcarcinomaisacommontypeoflungcancer,causingapproximately400,000deathsperyearworldwide.Genomicalterationsinsquamouscelllungcancershavenotbeencompr

2、ehensivelycharacterized,andnomolecularlytargetedagentshavebeenspecificallydevelopedforitstreatment.AspartofTheCancerGenomeAtlas,hereweprofile178lungsquamouscellcarcinomastoprovideacomprehensivelandscapeofgenomicandepigenomicalterations.Weshowthatthetumourtypeischaracterizedbycomplexgeno

3、micalterations,withameanof360exonicmutations,165genomicrearrangements,and323segmentsofcopynumberalterationpertumour.Wefindstatisticallyrecurrentmutationsin11genes,includingmutationofTP53innearlyallspecimens.Previouslyunreportedloss-of-functionmutationsareseenintheHLA-AclassImajorhistoco

4、mpatibilitygene.SignificantlyalteredpathwaysincludedNFE2L2andKEAP1in34%,squamousdifferentiationgenesin44%,phosphatidylinositol-3-OHkinasepathwaygenesin47%,andCDKN2AandRB1in72%oftumours.Weidentifiedapotentialtherapeutictargetinmosttumours,offeringnewavenuesofinvestigationforthetreatmento

5、fsquamouscelllungcancers.Lungcanceristheleadingcauseofcancer-relatedmortalityworldwide,adjacent,histologicallynormaltissuesresectedatthetimeofsurgeryleadingtoanestimated1.4milliondeathsin2010(ref.1).Thediscovery(n5137)orfromperipheralblood(n541).Allpatientsprovidedofrecurrentmutationsin

6、theepidermalgrowthfactorreceptor(EGFR)writteninformedconsenttoconductgenomicstudiesinaccordancekinase,aswellasfusionsinvolvinganaplasticlymphomakinase(ALK),withlocalInstitutionalReviewBoards.Thedemographiccharacteris-hasledtoamarkedchangeinthetreatmentofpatientswithlungticsaredescribedi

7、nSupplementaryTable1.2.Themedianfollow-up2–5adenocarcinoma,themostcommontypeoflungcancer.Morerecentforthecohortwas15.8months,and60%ofpatientswerealiveatthedatahavesuggestedthattargetingmutationsinBRAF,AKT1,ERBB2timeofthelastfollow-up(dataupdatedinNovember2011).Ninety-sixandPIK3

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。